Oncotarget

Research Papers:

Mitochondrial ATF2 translocation contributes to apoptosis induction and BRAF inhibitor resistance in melanoma through the interaction of Bim with VDAC1

Zongwei Gao _, Qingjuan Shang, Zhaoyun Liu, Chun Deng and Chunbao Guo

PDF  |  HTML  |  Supplementary Files  |  How to cite

Oncotarget. 2015; 6:36338-36353. https://doi.org/10.18632/oncotarget.5537

Metrics: PDF 1937 views  |   HTML 2187 views  |   ?  


Abstract

Zongwei Gao1,2,*, Qingjuan Shang1,2,*, Zhaoyun Liu1,*, Chun Deng1,3, Chunbao Guo1

1Laboratory of Surgery, Children's Hospital of Chongqing Medical University, Ministry of Education Key Laboratory of Child Development and Disorders, Chongqing, P. R. China

2Department of Pathology, Linyi People's Hospital, Linyi, Shandong, P. R. China

3Department of Neonatology, Children's Hospital of Chongqing Medical University, Chongqing, P. R. China

*These authors have contributed equally to this work

Correspondence to:

Chunbao Guo, e-mail: [email protected], [email protected]

Keywords: mitochondria, ATF2, Bim, VDAC1, Mcl-1

Received: June 26, 2015     Accepted: September 29, 2015     Published: October 09, 2015

ABSTRACT

Background: The mitochondrial accumulation of ATF2 is involved in tumor suppressor activities via cytochrome c release in melanoma cells. However, the signaling pathways that connect mitochondrial ATF2 accumulation and cytochrome c release are not well documented.

Methods: Several melanoma cell lines, B16F10, K1735M2, A375 and A375-R1, were treated with paclitaxel and vemurafenib to test the function of mitochondrial ATF2 and its connection to Bim and voltage-dependent anion channel 1 (VDAC1). Immunoprecipitation analysis was performed to investigate the functional interaction between the involved proteins. VDAC1 oligomerization was evaluated using an EGS-based crosslinking assay.

Results: The expression and migration of ATF2 to the mitochondria accounted for paclitaxel stimuli and acquired resistance to BRAF inhibitors. Mitochondrial ATF2 facilitated Bim stabilization through the inhibition of its degradation by the proteasome, thereby promoting cytochrome c release and inducing apoptosis in B16F10 and A375 cells. Studies using B16F10 and A375 cells genetically modified for ATF2 indicated that mitochondrial ATF2 was able to dissociate Bim from the Mcl-1/Bim complex to trigger VDAC1 oligomerization. Immunoprecipitation analysis revealed that Bim interacts with VDAC1, and this interaction was remarkably enhanced during apoptosis.

Conclusion: These results reveal that mitochondrial ATF2 is associated with the induction of apoptosis and BRAF inhibitor resistance through Bim activation, which might suggest potential novel therapies for the targeted induction of apoptosis in melanoma therapy.


Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 5537